In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Auxilium Pharmaceuticals, Inc.

http://www.auxilium.com/

Latest From Auxilium Pharmaceuticals, Inc.

Dexcom’s Q2 Earnings Exceed Wall Street Expectations; Holds G7 Launch

Dexcom expects 2020 revenues to reach $1.85bn driven by new patient adoption of its CGM device, but will not launch its next-gen G7 this year. 

Diabetic Care Coronavirus COVID-19

Medtronic/Tandem Patent Agreement Paves Way For Diabetes Product Development

Tandem Diabetes Care and Medtronic have signed a patent cross-license agreement that paves the way for joint development of future diabetes products and services while avoiding potential legal disagreements.

Diabetic Care Deals

More Positive Data For Recordati Cushing's Drug

With Isturisa, licensed last year from Novartis, it seems as though the Italian drugmaker has got hold of a therapy that could become lucrative, as well as highly effective for Cushing's disease.

Rare Diseases Clinical Trials

FDA Looks Ahead To Complex Product-Specific Guidances

The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.

Guidance Documents Generic Drugs
See All

Company Information

  • Other Names / Subsidiaries
    • Actient Pharmaceuticals LLC
    • Slate Pharmaceuticals
UsernamePublicRestriction

Register